NEKTAR THERAPEUTICS (NKTR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 40M 80M 120M Q3 '21: 100.4M Q4 '21: 101.9M Q1 '22: 103.1M Q2 '22: 96.3M Q3 '22: 95M Q4 '22: 92.1M Q1 '23: 88.8M Q2 '23: 87.7M Q3 '23: 88.3M Q4 '23: 90.1M Q1 '24: 90.2M Q2 '24: 93.2M Q3 '24: 93.1M Q4 '24: 98.4M Q1 '25: 87.2M Q2 '25: 74.9M Q3 '25: 62.6M Q4 '25: 55.2M Q1 '26: 55.6M Q2 '26: 54.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

-1.5M 0 1.5M 3M 4.5M Q4 '10: 1.7M Q1 '11: 3.4M Q2 '11: -585K Q3 '11: 2.8M Q4 '11: 3M Q4 '10 Q1 '11 Q2 '11 Q3 '11 Q4 '11

Operating Income TTM

-600M -400M -200M 0 200M 400M 600M Q3 '21: -443.9M Q4 '21: -446.1M Q1 '22: -453.3M Q2 '22: -495.9M Q3 '22: -436.6M Q4 '22: -376.2M Q1 '23: -394.3M Q2 '23: -292.1M Q3 '23: -282.6M Q4 '23: -263.7M Q1 '24: -164.4M Q2 '24: -163.6M Q3 '24: -153.1M Q4 '24: -105.2M Q1 '25: -114.3M Q2 '25: -100.8M Q3 '25: -98.1M Q4 '25: -140.1M Q1 '26: -134.6M Q2 '26: -140.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-600M -400M -200M 0 200M 400M 600M Q3 '21: -495.4M Q4 '21: -523.8M Q1 '22: -491.3M Q2 '22: -524.8M Q3 '22: -454.2M Q4 '22: -368.2M Q1 '23: -414.8M Q2 '23: -306.9M Q3 '23: -293.7M Q4 '23: -276.1M Q1 '24: -175.8M Q2 '24: -177.1M Q3 '24: -168.3M Q4 '24: -119M Q1 '25: -133M Q2 '25: -122.3M Q3 '25: -120.7M Q4 '25: -164.1M Q1 '26: -158.1M Q2 '26: -157.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 15M 30M 45M Q1 '21: 21.4M Q2 '21: 23.3M Q3 '21: 23.1M Q4 '21: 24.9M Q1 '22: 24.5M Q2 '22: 21.9M Q3 '22: 21.6M Q4 '22: 21.6M Q1 '23: 23.4M Q2 '23: 25.3M Q3 '23: 32.7M Q4 '23: 33.8M Q1 '24: 35.2M Q2 '24: 38M Q3 '24: 30M Q4 '24: 30.7M Q1 '25: 22.2M Q2 '25: 12.4M Q3 '25: 8M Q4 '25: 0 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Operating Cash Flow TTM

-450M -300M -150M 0 150M 300M 450M Q3 '21: -359.8M Q4 '21: -412.7M Q1 '22: -424M Q2 '22: -416.1M Q3 '22: -397.8M Q4 '22: -304M Q1 '23: -267.5M Q2 '23: -244M Q3 '23: -203.3M Q4 '23: -192.6M Q1 '24: -188.6M Q2 '24: -174.8M Q3 '24: -176.6M Q4 '24: -175.7M Q1 '25: -176.9M Q2 '25: -184.9M Q3 '25: -189.7M Q4 '25: -208.5M Q1 '26: -203.8M Q2 '26: -233.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-450M -300M -150M 0 150M 300M 450M Q3 '21: -370.6M Q4 '21: -427.6M Q1 '22: -440.3M Q2 '22: -429.9M Q3 '22: -408.9M Q4 '22: -309.7M Q1 '23: -269.4M Q2 '23: -245.3M Q3 '23: -204.4M Q4 '23: -193.5M Q1 '24: -189.2M Q2 '24: -175.4M Q3 '24: -177.8M Q4 '24: -177.2M Q1 '25: -178.2M Q2 '25: -186.1M Q3 '25: -190.4M Q4 '25: -208.7M Q1 '26: -203.9M Q2 '26: -234M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q3 '19: 175.4M Q2 '20: 178.3M Q3 '20: 179.1M Q1 '21: 181.4M Q2 '21: 182.7M Q3 '21: 184.1M Q1 '22: 185.8M Q2 '22: 186.8M Q3 '22: 187.6M Q1 '23: 188.9M Q2 '23: 189.7M Q3 '23: 190.4M Q1 '24: 194.7M Q2 '24: 13.9M Q3 '24: 13.9M Q1 '25: 14.1M Q2 '25: 14.1M Q3 '25: 18.9M Q1 '26: 24.7M Q2 '26: 33.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-900.00 -600.00 -300.00 0.00 300.00 600.00 900.00 Q3 '21: -2.72 Q4 '21: -792.07 Q1 '22: -791.88 Q2 '22: -792.04 Q3 '22: -791.65 Q4 '22: -1.97 Q1 '23: -2.21 Q2 '23: -1.63 Q3 '23: -1.56 Q4 '23: -1.46 Q1 '24: -0.92 Q2 '24: -4.41 Q3 '24: -6.83 Q4 '24: -8.68 Q1 '25: -12.11 Q2 '25: -11.30 Q3 '25: -10.51 Q4 '25: -10.03 Q1 '26: -8.23 Q2 '26: -6.51 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.